Viewing StudyNCT05898828



Ignite Creation Date: 2024-05-06 @ 7:06 PM
Last Modification Date: 2024-10-26 @ 3:00 PM
Study NCT ID: NCT05898828
Status: WITHDRAWN
Last Update Posted: 2024-07-15
First Post: 2023-06-09

Brief Title: Phase III Evaluation of a Cancer Lysate Vaccine and MontanideR ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Conditions & Keywords Data

Conditions:
Name
Esophageal Cancer EsC
Neoplasms
Esophageal Neoplasms
Esophagus Neoplasm
Esophagus Cancer
Neoplasms Esophageal
Keywords:
Name View
Immunotherapy View
Cell Mediated Response View
immune subsets View
peripheral immune subsets View
CT antigens View
neoadjuvant chemoradiation therapy nCRT View
H1299 Cell Lysates View
EsC View